153 related articles for article (PubMed ID: 32866213)
1. Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Weber MF; Yap S; Rankin NM; Ngo P; Veerman L; Banks E; Canfell K; O'Connell DL
PLoS One; 2020; 15(8):e0238018. PubMed ID: 32866213
[TBL] [Abstract][Full Text] [Related]
2. Health services costs for cancer care in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Yap S; Weber MF; Veerman L; Rankin N; Banks E; Canfell K; O'Connell DL
PLoS One; 2018; 13(7):e0201552. PubMed ID: 30059534
[TBL] [Abstract][Full Text] [Related]
3. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
Goldsbury DE; Feletto E; Weber MF; Haywood P; Pearce A; Lew JB; Worthington J; He E; Steinberg J; O'Connell DL; Canfell K
PLoS One; 2021; 16(11):e0260088. PubMed ID: 34843520
[TBL] [Abstract][Full Text] [Related]
4. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
5. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Vassallo A; Weber MF; Steinberg J; Webb PM; DeFazio A; Canfell K
PLoS One; 2023; 18(4):e0282851. PubMed ID: 37071628
[TBL] [Abstract][Full Text] [Related]
6. Cost of screening for lung cancer in Australia.
Marshall HM; Finn N; Bowman RV; Passmore LH; McCaul EM; Yang IA; Connelly L; Fong KM
Intern Med J; 2019 Nov; 49(11):1392-1399. PubMed ID: 31336016
[TBL] [Abstract][Full Text] [Related]
7. An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.
Bremner KE; Krahn MD; Warren JL; Hoch JS; Barrett MJ; Liu N; Barbera L; Yabroff KR
Palliat Med; 2015 Dec; 29(10):918-28. PubMed ID: 26330452
[TBL] [Abstract][Full Text] [Related]
8. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing.
Doble B; John T; Thomas D; Fellowes A; Fox S; Lorgelly P
Lung Cancer; 2017 May; 107():22-35. PubMed ID: 27316470
[TBL] [Abstract][Full Text] [Related]
10. Healthcare costs in patients with advanced non-small cell lung cancer and disease progression during targeted therapy: a real-world observational study.
Skinner KE; Fernandes AW; Walker MS; Pavilack M; VanderWalde A
J Med Econ; 2018 Feb; 21(2):192-200. PubMed ID: 29041833
[TBL] [Abstract][Full Text] [Related]
11. Relationship between use of general practice and healthcare costs at the end of life: a data linkage study in New South Wales, Australia.
Tran B; Falster MO; Girosi F; Jorm L
BMJ Open; 2016 Jan; 6(1):e009410. PubMed ID: 26743704
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare.
Sheehan DF; Criss SD; Chen Y; Eckel A; Palazzo L; Tramontano AC; Hur C; Cipriano LE; Kong CY
Cancer Med; 2019 Jan; 8(1):94-103. PubMed ID: 30575329
[TBL] [Abstract][Full Text] [Related]
13. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
[TBL] [Abstract][Full Text] [Related]
14. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
Evans WK; Will BP; Berthelot JM; Wolfson MC
Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care and emergency presentations for people with non-small cell lung cancer in New South Wales, Australia: A population-based study.
Yap S; Goldsbury D; Yap ML; Yuill S; Rankin N; Weber M; Canfell K; O'Connell DL
Lung Cancer; 2018 Aug; 122():171-179. PubMed ID: 30032827
[TBL] [Abstract][Full Text] [Related]
17. Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective.
Langton JM; Reeve R; Srasuebkul P; Haas M; Viney R; Currow D; Pearson SA
Br J Cancer; 2016 May; 114(11):1293-302. PubMed ID: 27115468
[TBL] [Abstract][Full Text] [Related]
18. Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.
Karanth S; Rajan SS; Revere FL; Sharma G
Am J Clin Oncol; 2019 Feb; 42(2):143-153. PubMed ID: 30300168
[TBL] [Abstract][Full Text] [Related]
19. Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history.
Reeve R; Srasuebkul P; Langton JM; Haas M; Viney R; Pearson SA;
BMC Palliat Care; 2017 Jun; 17(1):1. PubMed ID: 28637450
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
